Genomics and Population Health Action Collaborative
This collaborative was an ad hoc activity under the auspices of the Roundtable on Genomics and Precision Health at the National Academies of Sciences, Engineering, and Medicine (the National Academies). The products of the action collaborative do not necessarily represent the views of any one organization, the Roundtable, or the National Academies and have not been subjected to the review procedures of, nor are they a report or product of, the National Academies.
Integrating genomics at the population health level has the potential to increase our understanding of disease, improve public health, reduce health disparities, and promote genomic literacy. Current evidence for certain genomic applications suggests that health could be improved if these were implemented in the recommended populations. The Genomics and Population Health Action Collaborative was formed in 2015 with the goal of identifying challenges and potential best practices for the widespread integration of evidence-based genomics applications in population health programs. The action collaborative is in the process of concluding its work under the National Academies, however select projects will remain active through the CDC Office of Public Health Genomics.
The action collaborative engaged key stakeholders representing multiple sectors including academia, state and federal government, patient advocacy, industry, and health care delivery systems. The group included participants with experience in public health, medical genetics, implementation science, epidemiology, health communication, research, ethics, and law. A complete list of participants can be found here.
From 2015-2019, the action collaborative held four in-person meetings in Washington, DC. Materials from those meetings can be found here.
The products listed below were developed by the action collaborative participants and do not necessarily represent the views of any one organization, the Roundtable, or the National Academies and have not been subjected to the review procedures of, nor are they a report or product of, the National Academies.